Amgen Presents First Clinical Data for AMG 757 at SITC 2020; Data Marks the First Proof of Concept for a BiTE® Molecule in Thoracic Malignancy and Further Demonstrates Potential of BiTE® Immuno-Oncology Platform in Solid Tumors

Press/Media

PeriodNov 9 2020

Media coverage

11

Media coverage